Compared to the normal Lp(a) group, patients with elevated Lp(a) exhibited higher rates of myocardial infarction, stroke, repeat revascularization, and cardiovascular death, aligning with prior research highlighting Lp(a)’s pro-atherogenic and pro-thrombotic properties as key contributors to adverse cardiovascular outcomes. This evidence concerns the gene LPA and myocardial infarction.